Clinical trial
Antidiabetic Medications and Risk of Cancer
NCT07628556 is registered in ClinicalTrials.gov with University of Pecs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antidiabetic Medications and Risk of Cancer
- Lead sponsor
- University of Pecs
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 15, 2025
- Completion date
- December 30, 2025
- Enrollment
- 74,799 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer